HYPERFINE INC (NASDAQ: HYPR)

Exchange: NASDAQ (NAS)
Ticker: HYPR
Korean Name: 하이퍼파인
Share Price (2025-06-02): $1.01 (+67.63%)
Volume (2025-06-02): 15,078,731

---

1. Introduction

HYPERFINE INC is a public medical technology company specializing in ultra-low-field, portable magnetic resonance imaging (MRI) systems. Its flagship product, the Swoop® system, integrates AI-powered image reconstruction to deliver brain imaging at the point of care without the need for dedicated MRI suites. The company trades on NASDAQ under the ticker HYPR.

---

2. Corporate Structure

• Headquarters:
  • Guilford, Connecticut (351 New Whitfield St.)
  • Palo Alto, California (3000 El Camino Real, Bldg. 4, Suite 100)
• Founded: 2014
• Employees: 51–200 (LinkedIn estimate)
• Industry: Medical Equipment Manufacturing
• CIK: 0001833769

---

3. Developments and News

FDA Clearances and Product Advancements

• May 2025: U.S. Food and Drug Administration (FDA) clearance granted for the next-generation Swoop® system powered by Optive AI™ software.
• Optive AI™ software enhances image clarity at 0.064 T field strength using deep-learning reconstruction.

SEC Filings

• May 13, 2025 (424B5 Prospectus):
  • Aggregate offering of up to $50 million of Class A common stock.
  • 898,119 shares sold for $1.01 million; $48.99 million remaining capacity.
• May 19, 2025 (8-K, Item 5.07):
  • Disclosure of material events, including update on revenue trends and risk factors.
• May 23, 2025 (8-K, Item 5.02):
  • Reporting of significant corporate changes, including updates related to management personnel.

Investor and Industry Engagement

• Participation at ASNR25 (American Society of Neuroradiology Annual Meeting) with clinical sessions and demonstrations.
• LinkedIn announcements regarding the company's growth strategy in expanding into new hospital sites and neurology offices.

---

4. Financial and Strategic Analysis

Key Metrics (Trailing Twelve Months)

Metric	Value
Revenue	$11.73 M
Net Income	–$40.29 M
Diluted EPS	–0.54
Total Cash (mrq)	$33.09 M
Total Debt/Equity (mrq)	0.65%
Levered Free Cash Flow	–$22.32 M

Valuation and Trading Data

Metric	Value
Market Cap (intraday)	$76.76 M
52-Week Range	$0.533–$1.90
Beta (5Y Monthly)	0.95
Price/Sales (TTM)	3.77
Price/Book (mrq)	1.09
EV/Revenue	1.20

Stock Performance

• 2025-06-02: Share price at $1.01, reflecting a 67.63% increase from the prior close of $0.6025.
• Average Volume (TTM): 1,121,619 shares.

Capital Raising

• Under the Sales Agreement with B. Riley Securities, Inc., proceeds are intended for:
  • Operational enhancements
  • Research and development
  • Market expansion

---

5. Market Position and Industry Context

• Core Product: Swoop® portable MRI—first FDA-cleared, ultra-low-field (0.064 T) system for point-of-care brain imaging.
• AI Integration: Optive AI™ software is designed to improve image quality through continuous software updates.
• Clinical Settings: The Swoop® system can be utilized in ICU, emergency departments, neurology clinics, and pediatric care.
• Competitive Landscape: Positioned within the market for portable, point-of-care MRI solutions, the Swoop® system provides an alternative to traditional high-field MRI systems requiring extensive infrastructure.

---

TL;DR

• On June 2, 2025, HYPR shares closed at $1.01, representing a 67.63% gain, with trading volume exceeding 15 million shares.
• FDA clearance was received in May 2025 for the next-generation Swoop® system and the Optive AI™ platform, enhancing image quality in ultra-low-field MRI.
• SEC filings in May 2025 detail a $50 million equity offering (898,119 shares sold to date) and significant corporate updates.
• Financials show $11.73 million in revenue (TTM), a net loss of $40.29 million, and $33.09 million in cash as of the most recent quarter.
• Upcoming events include earnings scheduled between August 6–11, 2025, with ongoing expansion into hospital and neurology office settings.